| Financial Year |
March 31 2023 |
| Monetary Funds |
134,487,900.68 |
| Held-for-trading Financial Assets |
627,772,573.30 |
| Notes Receivable |
-- |
| Accounts Receivable |
154,800,094.43 |
| Advances to Suppliers |
9,592,237.02 |
| Other Receivables |
1,047,360.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
85,042,949.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,056,383.44 |
| Total Current Assets |
1,103,142,533.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
15,448,414.50 |
| Fixed Assetes |
583,569,690.97 |
| Under-construction Projects |
405,588.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,465,875.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
14,267,475.60 |
| Other Non-Current Assets |
2,347,311.20 |
| Sub-Total of Non-Current Assets |
758,001,942.02 |
| Total Assets |
1,861,144,475.10 |
| Short-Term Loans |
110,092,888.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,000,000.00 |
| Accounts Payable |
38,906,783.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,500,586.52 |
| Taxes Payable |
2,453,084.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
747,705.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
179,182,012.08 |
| Long-term Loans |
55,183,037.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
97,661,988.41 |
| Total Liabilities |
276,844,000.49 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
955,982,235.21 |
| Surplus Reserve |
59,987,761.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
446,443,818.00 |
| Minority Stockholder's Interest |
1,886,659.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,582,413,814.98 |
| Owner's Equity（Stockholder's Equity） |
1,584,300,474.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,861,144,475.10 |
